Due to the absence of a reliable diagnostic biomarker, CIDP is often misdiagnosed or diagnosed with delays. The condition was first defined by Peter Dyck in 1975. Since then, over 15 sets of ...

This subcutaneous (SC) injection is proposed as a monotherapy for the treatment of adult patients with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy (CIDP).

which has exacerbated the issue since clinical trials require a single set of eligibility criteria to be met that may not have considered these emerging differences. Closing this gap in scientific ...

The Center for American Progress submitted a comment on the Office of Personnel Management’s proposed revisions to the criteria for making salary determinations based on salary history.

Arthritis Action, a UK-based charity, estimates that approximately 10 million people in the UK suffer from some form of arthritis, which involves chronic joint inflammation that often causes ...

The compan Immunovant's batoclimab shows strong efficacy in MG & CIDP, but shifts focus to the lead drug IMVT-1402 for these indications to induce deeper, lasting relief. Immunovant and Roivant ...

Researchers presented the case of a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who experienced syncope and new-onset bifascicular block while being treated with intravenous ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease ...

and immune globulin-based products Hyqvia and Gammagard Liquid for chronic inflammatory demyelinating polyneuropathy (CIDP).

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast ...

Chronic inflammation refers to a prolonged inflammatory response that involves a progressive change in the type of cells present at the site of inflammation. It is characterized by the ...

At the World Congress of Gastroenterology in September, I had the opportunity to debate the benefits of a 'top-down' approach to the treatment of Crohn's disease, beginning with biologic (anti ...